SCHEMBL1269665

SCHEMBL1269665

O=C(c1nc(NS(=O)(=O)c2ccc(Cl)cc2Cl)ccc1Sc1ccc(S(=O)(=O)N2CCCCC2)cc1)C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.40
▸ ALDH1A1 P00352 6/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 6/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ LMNA P02545 3/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ CTDSP1 Q9GZU7 1/20 0.36
▸ APOBEC3G Q9HC16 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269493 0.99 HTT (0.38) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1268682 0.92 KMT2A (0.43) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1268515 0.90 ALDH1A1 (0.41) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1269628 0.90 CCKBR (0.43) HTTALDH1A1MEN1KMT2ALMNA
SCHEMBL1269953 0.89 CCKBR (0.42) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL1269276 0.89 MAPT (0.41) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1268953 0.89 ALDH1A1 (0.45) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1268898 0.88 PTGDR2 (0.40) HTTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1268967 0.87 PTGDR (0.36) CNR1EPHX2
SCHEMBL1269783 0.86 ALDH1A1 (0.41) HTTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG HTT 1326/4885ALDH1A1 2237/4885KDM4E 2907/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG HTT 1326/4885ALDH1A1 2237/4885KDM4E 2907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback